Business
How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days – Motley Fool Australia
The biotech got a little help from Amazon’s AWS.
Moderna(NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine candidate, mRNA-1273, ready for a phase 1 clinical trial in just 42 days.
The biotech’s use of Amazon Web Services (AWS), the cloud-based computing service run by Amazon (NASDAQ:AMZN), enabled this quick development. Moderna runs its Drug Design Studio on AWS, which allows it to design its mRNA drug candidates quickly.
The potential drugs ar…
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Noosa News20 hours agoPolice to get on-the-spot protection powers for DV victims
-
Noosa News24 hours agoDingoes bite 3 women on K’gari